BD211 Drug Product

· Shanghai BDgene Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BD211 Drug Product, covering 2025-05-18 to 2025-05-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety and Efficacy of the BD211 Drug Product in β-Thalassemia Major Participants [NA]